These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16901395)

  • 21. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ottmann OG; Wassmann B
    Hematology Am Soc Hematol Educ Program; 2005; ():118-22. PubMed ID: 16304368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges.
    Thomas DA
    Hematology Am Soc Hematol Educ Program; 2007; ():435-43. PubMed ID: 18024662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Zhang FH; Ling YW; Zhai X; Zhang Y; Huang F; Fan ZP; Zhou HS; Jiang QL; Sun J; Liu QF
    Hematology; 2013 May; 18(3):151-7. PubMed ID: 23394269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia.
    Thomas DA; O'Brien S; Cortes J; Kantarjian H
    Curr Hematol Malig Rep; 2007 Jul; 2(3):183-9. PubMed ID: 20425368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
    Wernstedt P; Brune M; Andersson PO; Gustavsson B; Stockelberg D; Wadenvik H
    Bone Marrow Transplant; 2002 Dec; 30(12):971-3. PubMed ID: 12476293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Philadelphia-positive acute lymphoblastic leukemia: current treatment options.
    Liu-Dumlao T; Kantarjian H; Thomas DA; O'Brien S; Ravandi F
    Curr Oncol Rep; 2012 Oct; 14(5):387-94. PubMed ID: 22669492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
    Fielding AK; Rowe JM; Richards SM; Buck G; Moorman AV; Durrant IJ; Marks DI; McMillan AK; Litzow MR; Lazarus HM; Foroni L; Dewald G; Franklin IM; Luger SM; Paietta E; Wiernik PH; Tallman MS; Goldstone AH
    Blood; 2009 May; 113(19):4489-96. PubMed ID: 19244158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing paradigm of the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ohno R
    Curr Hematol Malig Rep; 2010 Oct; 5(4):213-21. PubMed ID: 20652453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Ottmann OG; Wassmann B; Pfeifer H; Giagounidis A; Stelljes M; Dührsen U; Schmalzing M; Wunderle L; Binckebanck A; Hoelzer D;
    Cancer; 2007 May; 109(10):2068-76. PubMed ID: 17429836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
    Yoshimitsu M; Fujiwara H; Ozaki A; Hamada H; Matsushita K; Arima N; Tei C
    Int J Hematol; 2008 Oct; 88(3):331-335. PubMed ID: 18696183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords.
    Swords R
    Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted chronic myeloid leukemia therapy: seeking a cure.
    Fausel C
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl A):8-12. PubMed ID: 17970609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Blood; 2010 Nov; 116(18):3409-17. PubMed ID: 20656928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.
    Schultz KR; Carroll A; Heerema NA; Bowman WP; Aledo A; Slayton WB; Sather H; Devidas M; Zheng HW; Davies SM; Gaynon PS; Trigg M; Rutledge R; Jorstad D; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B;
    Leukemia; 2014 Jul; 28(7):1467-71. PubMed ID: 24441288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
    Wassmann B; Pfeifer H; Goekbuget N; Beelen DW; Beck J; Stelljes M; Bornhäuser M; Reichle A; Perz J; Haas R; Ganser A; Schmid M; Kanz L; Lenz G; Kaufmann M; Binckebanck A; Brück P; Reutzel R; Gschaidmeier H; Schwartz S; Hoelzer D; Ottmann OG
    Blood; 2006 Sep; 108(5):1469-77. PubMed ID: 16638934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives.
    Lee HJ; Thompson JE; Wang ES; Wetzler M
    Cancer; 2011 Apr; 117(8):1583-94. PubMed ID: 21472706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04.
    Manabe A; Kawasaki H; Shimada H; Kato I; Kodama Y; Sato A; Matsumoto K; Kato K; Yabe H; Kudo K; Kato M; Saito T; Saito AM; Tsurusawa M; Horibe K
    Cancer Med; 2015 May; 4(5):682-9. PubMed ID: 25641907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic myeloid leukemia with imatinib mesylate.
    Ohno R
    Int J Clin Oncol; 2006 Jun; 11(3):176-83. PubMed ID: 16850123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
    Tachibana T; Numata A; Tanaka M; Motohashi K; Fujisawa S; Fujita H; Sakai R; Tomita N; Maruta A; Ishigatsubo Y; Kanamori H
    Leuk Lymphoma; 2011 Jul; 52(7):1376-9. PubMed ID: 21438838
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stem cell transplantation.
    Takami A; Shimadoi S; Sugimori C; Takemoto K; Shibayama M; Yoshida T; Murayama T; Nagai K; Miyamura K; Asakura H; Nakao S
    Int J Hematol; 2006 Aug; 84(2):170-3. PubMed ID: 16926141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.